Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comprehensive clinical study of integrins in acute lymphoblastic leukemia indicates a role of α6/CD49f in persistent minimal residual disease and α5 in the colonization of cerebrospinal fluid.
Shah Scharff BFS, Modvig S, Thastrup M, Levinsen M, Degn M, Ryder LP, Schmiegelow K, Christensen C, Marquart HV. Shah Scharff BFS, et al. Among authors: thastrup m. Leuk Lymphoma. 2020 Jul;61(7):1714-1718. doi: 10.1080/10428194.2020.1731500. Epub 2020 Feb 28. Leuk Lymphoma. 2020. PMID: 32107949 No abstract available.
Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study.
Thastrup M, Marquart HV, Levinsen M, Grell K, Abrahamsson J, Albertsen BK, Frandsen TL, Harila-Saari A, Lähteenmäki PM, Niinimäki R, Pronk CJ, Ulvmoen A, Vaitkevičienė G, Taskinen M, Schmiegelow K; Nordic Society of Pediatric Hematology and Oncology (NOPHO). Thastrup M, et al. Leukemia. 2020 Feb;34(2):336-346. doi: 10.1038/s41375-019-0570-1. Epub 2019 Sep 18. Leukemia. 2020. PMID: 31534171
Correction: Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study.
Thastrup M, Marquart HV, Levinsen M, Grell K, Abrahamsson J, Albertsen BK, Frandsen TL, Harila-Saari A, Lähteenmäki PM, Niinimäki R, Pronk CJ, Ulvmoen A, Vaitkevičienė G, Taskinen M, Schmiegelow K; Nordic Society of Pediatric Hematology and Oncology (NOPHO). Thastrup M, et al. Leukemia. 2020 Oct;34(10):2822. doi: 10.1038/s41375-020-0821-1. Leukemia. 2020. PMID: 32269320
Flow cytometric analysis of cerebrospinal fluid improves detection of leukaemic blasts in infants with acute lymphoblastic leukaemia.
Thastrup M, Marquart HV, Levinsen M, Modvig S, Abrahamsson J, Albertsen BK, Frost BM, Harila-Saari A, Pesola J, Ulvmoen A, Wojcik DM, Taskinen M, Hoffmann M, Lausen B, Schmiegelow K; Nordic Society of Paediatric Haematology, Oncology (NOPHO). Thastrup M, et al. Br J Haematol. 2021 Oct;195(1):119-122. doi: 10.1111/bjh.17769. Epub 2021 Aug 15. Br J Haematol. 2021. PMID: 34396501
Does minimal central nervous system involvement in childhood acute lymphoblastic leukemia increase the risk for central nervous system toxicity?
Anastasopoulou S, Harila-Saari A, Als-Nielsen B, Eriksson MA, Heyman M, Johannsdottir IM, Marquart HV, Niinimäki R, Pronk CJ, Schmiegelow K, Vaitkeviciene G, Thastrup M, Ranta S. Anastasopoulou S, et al. Among authors: thastrup m. Pediatr Blood Cancer. 2022 Jul;69(7):e29745. doi: 10.1002/pbc.29745. Epub 2022 Apr 30. Pediatr Blood Cancer. 2022. PMID: 35488712
Deep Proteome Analysis of Cerebrospinal Fluid from Pediatric Patients with Central Nervous System Cancer.
Mirian C, Østergaard O, Thastrup M, Modvig S, Foss-Skiftesvik J, Skjøth-Rasmussen J, Berntsen M, Britze J, Yde Nielsen AC, Mathiasen R, Schmiegelow K, Olsen JV. Mirian C, et al. Among authors: thastrup m. J Proteome Res. 2024 Nov 1;23(11):5048-5063. doi: 10.1021/acs.jproteome.4c00471. Epub 2024 Oct 9. J Proteome Res. 2024. PMID: 39382389 Free PMC article.
Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade.
Nazerai L, Willis SC, Yankilevich P, Di Leo L, Bosisio FM, Frias A, Bertolotto C, Nersting J, Thastrup M, Buus S, Thomsen AR, Nielsen M, Rohrberg KS, Schmiegelow K, De Zio D. Nazerai L, et al. Among authors: thastrup m. Oncoimmunology. 2022 Dec 17;12(1):2158610. doi: 10.1080/2162402X.2022.2158610. eCollection 2023. Oncoimmunology. 2022. PMID: 36545256 Free PMC article.